Area of focus

Digital Health

Technology is changing the way the health care industry operates. With changes come new challenges and opportunities — as well as a dramatic shift in the competitive and regulatory landscape. We bring a real-world sensibility to your challenges, helping you to remain competitive and compliant everywhere you operate. Our cross-jurisdictional team of more than 40 life sciences and health care lawyers with a focus on digital health take a technology-based approach to counseling on digital health products and...

Representative experience

Advising a leading pharmaceutical company in its digital health strategy in 21 jurisdictions.

Representing a high-technology company in connection with its life science business ventures, including exclusive licenses and joint ventures, to develop digital health products.

Advising several pharmaceutical and medical device companies on the regulatory status and the dissemination and marketing of mobile applications.

Advising a leading consumer product company on the development and classification of a consumer-oriented wearable sensor and associated mobile application.

Assisting a major diabetes manufacturer in seeking PMA approval for a sensor augmented insulin pump.

Advising on various regulatory aspects of international telemedicine, including cross-border healthcare, data privacy, and medical device aspects.

Advising a number of clients on the classification and regulation of software for communication between medical devices and physicians’/patients’ smartphones and agendas.

Advising a pharmaceutical company on compliance aspects, terms of use, and data privacy of a mobile health app for patients’ use.

Assisting a major pharmaceutical company with an enterprise-wide review of Telephone Consumer Protection Act compliance issues.

Advising a biopharmaceutical company on its agreement with a supplier of digital technologies (e.g., data capture solutions) for use in clinical trials.

Representing biotechnology company in administrative law proceedings related to financial penalty imposed by Ministry of Health concerning a mobile health app.

Assisting the German Federal Government in the IP clearance for the German e-health card.

Advising developers of wearable technology and digital health platforms on liability risk mitigation strategies.

Representing global technology company before EU national authorities in dispute with competitors concerning appropriate classification of software that supports a medical device.

Assisting medical device manufacturers with structuring their connected medical device services to facilitate cross-border data transfers and streamline EU data protection constraints.

Advising multiple global medical device manufacturers on the development of variations to existing medical devices for use in sports activities and/or a healthy lifestyle.

Co-authoring a study for the French CNIL on the regulation of connected health (“quantified self”) devices.

Hogan Lovells Publications

FDA wants to hear from you: Proposed framework for regulating output of digital health tools accompanying prescription drugs as labeling Pharmaceutical and Biotechnology Alert

On 20 November the Food and Drug Administration (FDA) published a request for comments on a proposed framework for regulating the output of digital health applications disseminated by or on ...

Quick view Full view

Hogan Lovells Publications

New pharmaceutical technologies usher in significant changes to liability laws Life Sciences and Health Care Videos

As more pharmaceutical manufacturers introduce digital components to their products, the industry is beginning to consider long-term implications around liability issues.

Quick view Full view
Loading data